About China Cord Blood Corporation
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Exchange: NYSE
- Symbol: CO
- Previous Close: $6.03
- 50 Day Moving Average: $5.86
- 200 Day Moving Average: $5.27
- 52-Week Range: $4.27 - $6.43
- Trailing P/E Ratio: 33.31
- Foreward P/E Ratio: 35.59
- P/E Growth: 0.00
- Market Cap: $440.21M
- Outstanding Shares: 73,003,000
- Beta: 0.95
- Net Margins: 13.38%
- Return on Equity: 5.30%
- Return on Assets: 1.93%
Companies Related to China Cord Blood Corporation:
- Debt-to-Equity Ratio: 0.24%
- Current Ratio: 3.49%
- Quick Ratio: 3.46%
What is China Cord Blood Corporation's stock symbol?
China Cord Blood Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."
When will China Cord Blood Corporation announce their earnings?
China Cord Blood Corporation is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
Who owns China Cord Blood Corporation stock?
China Cord Blood Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include GLG Partners LP (2.20%), Renaissance Technologies LLC (1.11%), PEAK6 Investments L.P. (0.31%), Dumac Inc. (0.23%), Quinn Opportunity Partners LLC (0.07%) and Advisory Research Inc. (0.06%).
Who sold China Cord Blood Corporation stock? Who is selling China Cord Blood Corporation stock?
China Cord Blood Corporation's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, PEAK6 Investments L.P. and Two Sigma Investments LP.
Who bought China Cord Blood Corporation stock? Who is buying China Cord Blood Corporation stock?
China Cord Blood Corporation's stock was purchased by a variety of institutional investors in the last quarter, including GLG Partners LP, Dumac Inc., Quinn Opportunity Partners LLC and State Street Corp.
How do I buy China Cord Blood Corporation stock?
Shares of China Cord Blood Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of China Cord Blood Corporation stock cost?
One share of China Cord Blood Corporation stock can currently be purchased for approximately $6.05.